Medical Condition News

RSS

Ramipril can effectively reduce risk of ESRD in obese patients

The angiotensin-converting enzyme inhibitor drug, ramipril, is particularly effective in lowering the risk of end-stage renal disease in obese patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.

29 Apr 2011

LEO Pharma introduces new Taclonex website for plaque psoriasis treatment

LEO Pharma Inc., a wholly-owned US subsidiary of LEO Pharma A/S, makers of Taclonex brand products, today announced the launch of an enhanced and expanded website at www.taclonex.com.

28 Apr 2011

CEL-SCI initiates Multikine Phase III trial in head and neck cancer

CEL-SCI Corporation announced today that it has commenced its global Phase III clinical trial for Multikine, the Company's flagship immunotherapy, at the Meenakshi Mission Hospital and Research Centre in Madurai, Tamil Nadu, India, the first clinical site in India.

28 Apr 2011

Study shows direct link between cotton swab use and ruptured eardrum

A study by Henry Ford Hospital shows a direct association between cotton swab use and ruptured eardrum. The study also shows that in most cases the rupture heals on its own and surgery is only necessary for the most severe cases.

28 Apr 2011

Roche introduces new Accu-Chek Mobile glucose monitoring device

Roche Diagnostics Canada, a trailblazer in the healthcare field, is proud to introduce Accu-Chek Mobile, the first strip-free blood glucose monitoring device available on the market.

From Roche Sequencing and Life Science 28 Apr 2011

Centocor Ortho Biotech receives FDA approval for Zytiga to treat prostate cancer

The U.S. Food and Drug Administration today approved Zytiga in combination with prednisone to treat patients with late-stage castration-resistant prostate cancer who have received prior docetaxel.

28 Apr 2011

FDA accepts OncoMed's IND filing for OMP-18R5 in Phase 1 clinical trial for advanced solid tumors

OncoMed Pharmaceuticals, Inc., a company developing novel therapeutics that target cancer stem cells or tumor-initiating cells, today announced that the FDA has accepted an IND filing for OMP-18R5, which allows OncoMed to commence Phase 1 clinical testing.

28 Apr 2011

FDA approves orphan drug designation for Cytrx’s INNO-206 to treat pancreatic cancer

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that its tumor-targeting pro-drug candidate INNO-206 has been approved for orphan drug designation for the treatment of patients with pancreatic cancer by the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA). CytRx holds the exclusive worldwide development and commercialization rights to INNO-206.

28 Apr 2011

Positive results from Otonomy's OTO-104 Phase 1b study in Meniere's disease

Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced positive data from a Phase 1b study of the company's lead product candidate, OTO-104, in patients with Meniere's disease.

28 Apr 2011

WellPoint offers health coaches for employees to resolve clinical issues

Most of us agree, there have been times we've needed a coach. Our closets are a mess and our bank account(s), even more so. Marital bliss is far from effortless, and our own teenage angst was a walk in the park compared to what we're currently living with.

28 Apr 2011

MGH's telestroke program selects Vidyo healthcare solution for video conferencing

Vidyo, Inc., the first company to deliver personal telepresence, today announced that the Partners Healthcare Telestroke Program at Massachusetts General Hospital - supporting 27 hospitals throughout Massachusetts, New Hampshire and Maine -- has deployed a revolutionary telemedicine communication and collaboration solution based on the company's award-winning platform.

28 Apr 2011

STAAR Surgical receives CE Mark approval for nanoFLEX Collamer IOL lens

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for its nanoFLEX Collamer Single Piece IOL which can be injected through a 2.2 mm incision with the nanoPOINT Injector System.

28 Apr 2011

Simple blood test can diagnose early Parkinson's disease

In Parkinson's disease, the human body generates antibodies to combat the amyloid-producing protein alpha synuclein early in the course of the disease. A simple blood test that measures these antibodies can facilitate early diagnosis of the disorder, writes Ludmilla Morozova-Roche and her associates at Umeå University in Sweden in the latest issue of the journal PLoS One.

28 Apr 2011

Experts to teach athletic trainers, medical providers on sports head injuries

Top experts from around the country will be at the University of North Carolina at Chapel Hill later this week to teach athletic trainers and medical providers how to prevent deaths and serious injuries among high school and college athletes.

28 Apr 2011

Collaborative approach can help improve Appalachian's health

According to the Centers for Disease Control and Prevention, residents of many Appalachian counties are three times more likely to die from diabetes than someone living in other counties in the same state, or in most other parts of the United States.

28 Apr 2011

DNA structure co-discoverer to present 'Curing Incurable Cancer' at Uofl event

James D. Watson, Ph.D., winner of the 1962 Nobel Prize with Francis Crick and Maurice Wilkins for the discovery of the double helical structure of DNA, will present "Curing Incurable Cancer" and attend other events associated with the Kentucky Derby. Watson's appearances are sponsored by the James Graham Brown Cancer Center at the University of Louisville.

28 Apr 2011

New microchip sensor can detect individual's respiratory rate

Researchers at Tyndall National Institute, UCC, Cork, have developed a microchip sensor that can detect a person's respiratory rate without any contact with the person under observation.

28 Apr 2011

Heart attacks in the morning are more serious

People who have a heart attack are likely to be more seriously affected if the attack happens in the morning, reveals research published ahead of print in Heart journal.

28 Apr 2011

Special-focus on postoperative cognitive dysfunction in older adults

Postoperative cognitive dysfunction (POCD) refers to a "mild but possibly long-lasting cognitive fogginess" occurring after surgery and anesthesia. The May issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS), presents a special-focus section on POCD in older adults—including the possible causes and preoperative evaluation of POCD risk.

28 Apr 2011

Health effects of Chernobyl nuclear crisis remain unknown 25 years after incident

Though it has been 25 years since a disastrous explosion at the Chernobyl nuclear power plant in Ukraine sent radioactive material into the air, affecting Russia, Ukraine and Belarus, as well as the rest of the world, "experts are still debating the long-term health effects of the disaster," the Los Angeles Times' "Booster Shots" blog reports.

28 Apr 2011